Wednesday, May 4, 2022
12:00 PM - 1:00 PM
Join Zoom Meeting
Synucleinopathies: From Molecular Maps to Intervention
Assistant Professor of Neurology, Harvard Medical School
Chief, Division of Movement Disorders at Brigham and Women’s Hospital
Principal Faculty at the Harvard Stem Cell Institute
Associate Member of the Broad Institute of Harvard and MIT

Vikram (Vik) Khurana is Chief of the Division of Movement Disorders at Brigham and Women’s Hospital. He is Principal Faculty at the Harvard Stem Cell Institute, and an Associate Member of the Broad Institute of Harvard and MIT. His clinical and research interests relate to neurodegenerative disorders focusing on Parkinson’s disease (PD) and related dementias, and rarer disorders including multiple system atrophy (MSA) and ataxias. In 2018, he was named a Robertson Investigator of the New York Stem Cell Foundation, in 2019 a George C. Cotzias Fellow of the American Parkinson’s Disease Association and in 2020 an investigator of the Aligning Science Across Parkinson’s Initiative. He is a member of the Board of Directors of the MSA Coalition.
Dr. Khurana is a medical graduate of the University of Sydney and obtained his Ph.D. in neurobiology from Harvard University. He completed his neurology residency at Brigham and Women’s and Massachusetts General Hospitals, and fellowship in movement disorders and ataxia at Massachusetts General Hospital. He received postdoctoral training at the Whitehead Institute for Biomedical Research (MIT), where he led some of the first studies to identify and reverse pathologies in human stem cells derived from PD patients (Science, 2013). This work has led to novel the discovery of novel drugs, currently in trial for Parkinson’s disease.

More recently, the Khurana laboratory has comprehensively mapped the consequences of misfolding of alpha-synuclein, the protein that aggregates in synucleinopathies like PD (Cell Systems 2017). These maps have shed light on disease mechanisms and novel functions for alpha-synuclein (Cell 2022 In Press). Current efforts focus on bringing stem-cell technologies toward targeted therapeutics for PD and related disorders.

Dr. Khurana has founded two biotech companies with a focus on CNS and neurodegenerative diseases.

Steps to claim CME credits for BWH Neurology Grand Rounds 2020-2021:
Text this code "PALLUY” to 1-857-214-2277.
  1. A link will be sent to your email. Click on the link and complete the evaluation. After you complete the evaluation, your CME will be recorded. You will then be able to download a PDF of your certificate.



If you have any questions about the CME credit, please contact Partners Office of Continuing Professional Development at PartnersCPD@partners.org.

The MGB CPD Team welcomes your feedback on their CME process. Please email Tracy Young-Pearse, Ph.D. and William R. Renthal, M.D., Ph.D. with your comments


Join Zoom Meeting


Chat Function will be available for Q&A prior to the end of the seminar

Meeting ID: 582 346 2701

One tap mobile
+16468769923,,5823462701# US (New York)
+13017158592,,5823462701# US (Washington D.C)

Dial by your location
    +1 646 876 9923 US (New York)
    +1 301 715 8592 US (Washington D.C)
    +1 312 626 6799 US (Chicago)
    +1 408 638 0968 US (San Jose)
    +1 669 900 6833 US (San Jose)
    +1 253 215 8782 US (Tacoma)
    +1 346 248 7799 US (Houston)

Find your local number: https://partners.zoom.us/u/kbdWW6C9V

Join by SIP
5823462701@zoomcrc.com
For questions, please contact Seminar Directors Tracy Young-Pearse, Ph.D. and William R. Renthal, M.D., Ph.D.
To subscribe to Neurology Grand Rounds distribution list please send an email to bwhneurology@partners.org